Detailed and atypical HLA‐E peptide binding motifs revealed by a novel peptide exchange binding assay

Detailed and atypical HLA‐E peptide binding motifs revealed by a novel peptide exchange binding assay

Diverse SIV and HIV epitopes that bind the rhesus homolog of HLA‐E, Mamu‐E, have recently been identified in SIVvaccine studies using a recombinant Rhesus cytomegalovirus (RhCMV 68‐1) vector, where unprecedented protection against SIV challenge was achieved. Additionally, several Mycobacterial pepti...

Bibliografski detalji
Glavni autori:	Walters, LC, McMichael, AJ, Gillespie, GM
Format:	Journal article
Jezik:	English
Izdano:	Wiley 2020

Slični predmeti

Discovery of HLA-E-presented epitopes: MHC-E/Peptide binding and t-cell recognition
od: Ruibal, P, i dr.
Izdano: (2022)

Definition of peptide binding motifs amongst the HLA-A*30 allelic group.
od: Krausa, P, i dr.
Izdano: (2000)

Author Correction: Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding.
od: Walters, LC, i dr.
Izdano: (2018)

Evidence of widespread binding of HLA class I molecules to peptides.
od: Frelinger, J, i dr.
Izdano: (1990)

Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity
od: Li, D, i dr.
Izdano: (2022)

Primary and secondary functions of HLA-E are determined by stability and conformation of the peptide-bound complexes
od: Walters, LC, i dr.
Izdano: (2022)

HLA-A2 subtypes are functionally distinct in peptide binding and presentation.
od: Barouch, D, i dr.
Izdano: (1995)

Identification of novel HIV-1-derived HLA-E-binding peptides
od: Hannoun, Z, i dr.
Izdano: (2018)

Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding
od: Walters, L, i dr.
Izdano: (2018)

A distinctive peptide binding motif for HLA-DRB1*0407, an HLA-DR4 subtype not associated with rheumatoid arthritis.
od: Davenport, M, i dr.
Izdano: (1997)

HLA class I binding motifs derived from random peptide libraries differ at the COOH terminus from those of eluted peptides.
od: Davenport, M, i dr.
Izdano: (1997)

Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding
od: Lucy C. Walters, i dr.
Izdano: (2018-08-01)

Significance of the six peptide-binding pockets of HLA-A2.1 in influenza A matrix peptide-specific cytotoxic T-lymphocyte reactivity.
od: Matsui, M, i dr.
Izdano: (1994)

Identification and characterization of heteroclitic peptides in TCR-binding positions with improved HLA-binding efficacy
od: Beatrice Cavalluzzo, i dr.
Izdano: (2021-02-01)

Tertiary motifs as building blocks for the design of protein‐binding peptides
od: Swanson, Sebastian, i dr.
Izdano: (2022)

Peptide binding predictions for HLA DR, DP and DQ molecules
od: Lund Ole, i dr.
Izdano: (2010-11-01)

Machine Learning Methods for Predicting HLA-Peptide Binding Activity
od: Heng Luo, i dr.
Izdano: (2015-01-01)

Machine Learning Methods for Predicting HLA–Peptide Binding Activity
od: Heng Luo, i dr.
Izdano: (2015-10-01)

Analysis of mutant HLA-A2 molecules. Differential effects on peptide binding and CTL recognition.
od: Tussey, L, i dr.
Izdano: (1994)

A novel method for HLA-peptide binding prediction and HLA supertype sub-typing
od: Zhao, Bing
Izdano: (2008)

Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity
od: Dapeng Li, i dr.
Izdano: (2022-03-01)

Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E.
od: O'Callaghan, C, i dr.
Izdano: (1998)

HLA-peptide tetrameric complexes.
od: Ogg, G, i dr.
Izdano: (1998)

TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide.
od: Braud, V, i dr.
Izdano: (1998)

Author Correction: Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding
od: Lucy C. Walters, i dr.
Izdano: (2018-11-01)

IMMUNOGENIC HIV VARIANT PEPTIDES THAT BIND TO HLA-B8 BUT FAIL TO STIMULATE CYTOTOXIC T-LYMPHOCYTE RESPONSES
od: Mcadam, S, i dr.
Izdano: (1995)

Structural Predictions of TCR/peptide/HLA DRB1*1501 binding
od: Chan, H, i dr.
Izdano: (2008)

HLAEquity: Examining biases in pan-allele peptide-HLA binding predictors
od: Anja Conev, i dr.
Izdano: (2024-01-01)

3pHLA-score improves structure-based peptide-HLA binding affinity prediction
od: Anja Conev, i dr.
Izdano: (2022-06-01)

Modeling Peptide–Protein Interactions by a Logo-Based Method: Application in Peptide–HLA Binding Predictions
od: Irini Doytchinova, i dr.
Izdano: (2024-01-01)

Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes.
od: Maenaka, K, i dr.
Izdano: (2000)

Chronic Beryllium Disease: revealing the role of beryllium ion and small peptides binding to HLA-DP2.
od: Marharyta Petukh, i dr.
Izdano: (2014-01-01)

Analysis of peptide-binding motifs for two disease associated HLA-DR13 alleles using an M13 phage display library.
od: Davenport, M, i dr.
Izdano: (1996)

IntroSpect: Motif-Guided Immunopeptidome Database Building Tool to Improve the Sensitivity of HLA I Binding Peptide Identification by Mass Spectrometry
od: Le Zhang, i dr.
Izdano: (2022-04-01)

High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation
od: Huisman, BD, i dr.
Izdano: (2023)

Adhesive and migratory effects of phosphophoryn are modulated by flanking peptides of the integrin binding motif.
od: Shigeki Suzuki, i dr.
Izdano: (2014-01-01)

Citrullination only infrequently impacts peptide binding to HLA class II MHC.
od: John Sidney, i dr.
Izdano: (2017-01-01)

FVIII peptides presented on HLA-DP and identification of an A3 domain peptide binding with high affinity to the commonly expressed HLA-DP4
od: Mariarosaria Miranda, i dr.
Izdano: (2024-12-01)

Promiscuous binding of invariant chain-derived CLIP peptide to distinct HLA-I molecules revealed in leukemic cells.
od: Marvin M van Luijn, i dr.
Izdano: (2012-01-01)

HLA-E-presented peptides as novel targets for HIV-1 therapy
od: S. Brackenridge, i dr.
Izdano: (2019-12-01)